Search results Search for: Search Refine your results by duration: Any Under 5 mins Under 20 mins Over 20 mins Sort by: Relevance Views Date Bringing Gene Therapies to Life: Navigating Scale Up, Partnerships, and Barriers Ben Josey Ph.D., Field Application Scientist, Corning Life Sciences Cell and gene therapies are rapidly advancing and with that, the need to effectively generate large volumes of viable cell and gene therapy products t... 2 weeks ago | 29 mins Speed up your scale up with Corning® HYPER technology Amit K Sharma Time to market with the right product becomes a key in today’s vaccine market condition. Traditional 2D stacked vessels have been widely accepted as p... August 25, 2022 5:00am Commercial Cell Therapy Experience Using Mycoplasma NAT For Product Release... John Duguid at Vericel Corporation, Lori Daane at bioMerieux and Mike Brewer at Thermo Fisher Scientific Full Title: Commercial Cell Therapy Experience Using Mycoplasma NAT For Product Release: Five-Year Review November 1, 2022 2:00pm Successful Scale Up of a High Yielding Viral Vector Suspension Platform to 500 L John Ketz, at Andelyn Biosciences, Denis Kole, at Pall Corporation and Benben Song, at Pall Corporation As gene therapies move toward commercialization, the journey to manufacture a high-quality product while achieving economies of scale and reducing fac... 1 month ago | 113 mins Material Requirements to Support Gene Therapy Development Clare Blue, Director of Analytical Development at Biogen and James Wilkinson, VP of Sales and Customer Success at Refeyn Manufacturing processes for gene therapy products are generally low yielding compared to production processes for other biologics. The material requir... 3 months ago | 73 mins Just in Time Release of CAR T Cell Therapies During Covid-19 Irving Ford at Bristol Myers Squibb and Lori Daane at bioMérieux Presented by Irving Ford, Site QA Head multi-product CAR T facility at Bristol Myers Squibb 4 months ago | 78 mins Regulatory Strategies For Rapid Sterility Testing... Dr. Michael J. Miller, at Microbiology Consultants, LLC and Lori Daane, at bioMérieux Full Title: Regulatory Strategies For Rapid Sterility Testing of Gene and Cell Therapy Products The need to utilize rapid sterility testing is gainin... 5 months ago | 122 mins Agreeing sustainable value-based contracts with payers: myths and realities Josie Godfrey, Malcom Qualie, Heather McDonald, John Pinching Value-based contracts (VBC) are increasingly considered by companies for many types of therapies, with some suggesting that VBC will become the defaul... 1 month ago | 62 mins CMC Progression from Early to Late Phase... Sarah Thomas, Vice President of Quality at REGENXBIO Inc. and Joanna Zmurko, NGS specialist at PathoQuest Full Title: CMC Progression from Early to Late Phase – Practical Considerations for Gene Therapy The principles for developing traditional biologics ... 5 months ago | 88 mins Just in Time Release of CAR T Cell Therapies During Covid-19 Irving Ford at Bristol Myers Squibb and Lori Daane at bioMérieux Presented by Irving Ford, Site QA Head multi-product CAR T facility at Bristol Myers Squibb 9 months ago | 78 mins Load more
